Login / Signup

Bevacizumab-containing regimen in relapsed/progressed brain tumors: a single-institution experience.

Amalia SchiavettiGiulia VarrassoMaria Giovanna MollaceCarlo DominiciEva FerraraPaola PapoffClaudio Di Biasi
Published in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2019)
BVZ/IRI association ± TMZ showed encouraging therapeutic activity and low toxicity in this series of relapsed/refractory brain tumors.
Keyphrases
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • multiple myeloma
  • hodgkin lymphoma
  • diffuse large b cell lymphoma
  • oxidative stress
  • metastatic colorectal cancer
  • oxide nanoparticles